More on OKYO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (9/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

OKYO Pharma (NQ:OKYO)
Delayed: 1.43 +0.05 (3.62%)
Prev. Close $1.38  
Open$1.42 
52 Wk High$ 
52 Wk Low$ 
Day High$1.43 
Day Low$1.35 
P/E N/A  
EPS$ 
Volume28,694 

Friends, Peers and Foes (?): OK11 (more...)

Jul 13, 2026 06:38 AM OKYO Pharma Ltd. (OKYO) PT Lowered to $5 at H.C. Wainwright
Jul 8, 2026 07:00 AM Form 6-K OKYO Pharma Ltd For: Jul 08
Jul 8, 2026 07:00 AM OKYO Pharma advances urcosimod into Phase 3 trial after FDA meeting
Jul 8, 2026 07:00 AM OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
Jul 7, 2026 07:00 AM Form 6-K OKYO Pharma Ltd For: Jul 07
Jul 7, 2026 07:00 AM OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium
Jun 17, 2026 04:15 PM Form 3 OKYO Pharma Ltd For: Mar 18 Filed by: Mantelli Flavio
Jun 10, 2026 05:00 PM Form 4 OKYO Pharma Ltd For: Jun 08 Filed by: BRANCACCIO JOHN P
Jun 10, 2026 05:00 PM Form 4 OKYO Pharma Ltd For: Jun 08 Filed by: Denoyer Bernard
Jun 10, 2026 05:00 PM Form 4 OKYO Pharma Ltd For: Jun 08 Filed by: Simon Willy Jules
View All Articles

Entities mentioned with OKYO

View All Entities